Thu.Sep 12, 2024

article thumbnail

Cause of Missouri H5 bird flu case remains a mystery, CDC says

STAT

Disease investigators have not been able to determine how a person in Missouri with no known exposures to animals or poultry became infected with an H5 bird flu virus, the principal deputy director of the Centers for Disease Control and Prevention said Thursday. But Nirav Shah said the ongoing investigation has turned up no evidence of onward spread of the virus, suggesting this case may turn out to be a one-off infection that defies explanation.

363
363
article thumbnail

How Lilly’s sustainability goals come face to face with massive growth

PharmaVoice

Eli Lilly’s head of ESG is maintaining a focus on sustainability even as the company’s expansion plans in weight loss drive a larger footprint and more social scrutiny.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: A rare disease program, portrayed as both lifeline and pharma handout, is set to expire

STAT

After his son Michael was diagnosed with a devastating, ultra-rare disease in 2019, Terry Pirovolakis dedicated himself to eradicating it.  Pirovolakis, a Canadian IT director, recruited academics and raised $3 million to design a gene therapy. He got Michael treated, an intervention that seems to have helped the 6-year-old stand on his heels for the first time and slow the course of a disease that can be severely cognitively and physically disabling.

360
360
article thumbnail

Three biotechs raise $700M in rare burst of IPO activity

BioPharma Dive

The offerings by Bicara, Zenas and MBX give a glimpse into what industry insiders describe as a backlog of mature startups waiting for the right opportunity to test public markets.

132
132
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Apple will offer millions of AirPod users a hearing aid. Can it convince them to use it?

STAT

After years of dabbling in hearing health, Apple earlier this week went all-in, announcing that AirPods Pro, the tech giant’s top wireless earbuds, will soon double as hearing aids for people with milder forms of hearing loss. Apple’s redoubled effort on hearing also includes software to test a person’s hearing and to customize the output of the hearing aid.

348
348
article thumbnail

RPS announces proposals to become Royal College

The Pharmacist

The Royal Pharmaceutical Society (RPS) has today (12 September) announced proposals to become the 'Royal College of Pharmacy', with charitable status. It said the suggestion was the outcome of a 'comprehensive independent review' of its constitution and governance, which has taken place over the past 18 months. As a Royal College, the RPS said it […] The post RPS announces proposals to become Royal College appeared first on The Pharmacist.

More Trending

article thumbnail

Gene therapy startup emerges with green light for first-of-its-kind trial

BioPharma Dive

Spun out of research at Nationwide Children’s Hospital, Vironexis claims it will be the first company to start a study testing a cancer drug delivered via the adeno-associated viruses commonly used in genetic medicines.

Hospitals 116
article thumbnail

STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion

STAT

Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate. Stephen Hoge, Moderna’s president, in an interview pointed to Moderna’s “massively productive R&D engine,” citing nine medicines in the late stages of development that he says could be filed with regulators over t

article thumbnail

Indian Immunologicals partners with ICMR for clinical development of India’s first Zika vaccine

Express Pharma

Indian Immunologicals (IIL), a vaccine manufacturer, has signed a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) to develop India’s first codon de-optimized live attenuated Zika vaccine. This partnership marks a significant step toward addressing the spread of the Zika virus, a mosquito-borne infection primarily transmitted by Aedes mosquitoes.

Vaccines 105
article thumbnail

STAT+: Can iTeos and GSK solve TIGIT’s troubles?

STAT

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I ate three dozen oysters last Saturday while taking a tour of the Island Creek Oyster Farm in Duxbury, Mass. AMA.

286
286
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Lilly $1.8 billion investment to bolster Irish manufacturing

European Pharmaceutical Review

Eli Lilly and Company is planning to invest a total of $1.8 billion in two manufacturing sites in Ireland , boosting its medicine production worldwide. Edgardo Hernandez , Executive Vice President and President of Lilly Manufacturing Operations, explained that the company ’s new investments will enhance production of medicines for diabetes, obesity and Alzheimer’s.

Diabetes 105
article thumbnail

A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids

STAT

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider behind Summit’s success? Why can’t Moderna turn a profit? And should we be giving weight loss drugs to kids? We talk about all that and more on this week’s episode of “The Readout LOUD.

307
307
article thumbnail

Welsh community pharmacies to get 'above-inflation investment'

The Pharmacist

The Welsh Government has announced an 'above-inflation investment' for community pharmacies in Wales – the details of which will be negotiated with Community Pharmacy Wales (CPW). Cabinet secretary for health and social care Mark Drakeford announced this week that he would uplift the pay of NHS staff on Agenda for Change contracts by 5.5%, and […] The post Welsh community pharmacies to get 'above-inflation investment' appeared first on The Pharmacist.

article thumbnail

STAT+: ‘Put him in jail.’ Steward CEO de la Torre skips hearing, now Congress is poised to hold him in contempt

STAT

Lawmakers in Washington turned their focus to the Steward Health Care bankruptcy scandal on Thursday, even as patients, doctors, and regulators across eight states continue to struggle with the hospital chain’s financially starved facilities. Senators hoped to grill Steward chief executive Ralph de la Torre at the hearing in the Capitol but had to make do verbally attacking an empty chair.

Hospitals 267
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Starmer says no extra NHS funding without big reforms

pharmaphorum

Keir Starmer has promised the biggest 'reimagining' of the NHS in its history but said there will be no more funding without sweeping reforms

116
116
article thumbnail

FDA is taking on tampons and ‘misleading’ ads starring Serena Williams

STAT

Good morning! I’ve decided today is the day that I must tell you about my favorite Instagram account: poeticpuppets. It’s an account (run by a Teresa with no H, not me!) where puppets present you with some delicious poetry bites. Enjoy! A lifeline or a pharma handout? Either way, this program is set to expire There’s an obscure U.S. government voucher program due to sunset at the end of this month.

article thumbnail

Wanbury announces new API product portfolio and launch plans

Express Pharma

Wanbury has announced the launch of its new active pharmaceutical ingredients (API) product portfolio for FY24-25. The company outlined a range of products to be commercialised, which cover therapeutic areas including anti-diabetics, antidepressants, anti-histamines, analgesics, anti-inflammatory drugs, antitussives, and anaesthetics. The new products, which are set to be launched in the upcoming fiscal year, include APIs like, Sertraline HCl, Diphenhydramine HCl, Diphenhydramine Citrate, Metfor

Diabetes 105
article thumbnail

STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more

STAT

Rise and shine, everyone, another busy day is on the way. However, this is also shaping up as a beautiful day as well, despite forecasts predicting rising heat. The skies are tranquil, birds are chirping, and the official mascots are chasing creatures on the Pharmalot campus. This calls for celebration with a cup of stimulation, and we are opening a new package of pecan pie for the occasion.

Packaging 140
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Pharma industry faces call to expand patient access in low- and middle-income countries

Express Pharma

The pharmaceutical industry is under pressure to ensure that vital health products are accessible to all, regardless of geographic location or socioeconomic status. A new report from the Access to Medicine Foundation provides an analysis of how some of the largest pharmaceutical companies are working to reach patients worldwide, particularly in low- and middle-income countries (LMICs), in pursuit of health equity.

article thumbnail

Moderna cuts spending, and Sarepta’s ‘curse’ on Califf

STAT

Good morning. If you’re following the European Society for Medical Oncology meeting that starts tomorrow, sign up for our ESMO in 30 Seconds newsletter. My colleague Drew Joseph is on the ground in Barcelona (and I’m very jealous of him). Onto the biotech news of the day.

article thumbnail

Fulcrum shares collapse as Sanofi-partnered muscular dystrophy drug fails key test

BioPharma Dive

The biotech will now suspend development of a drug prospect that Sanofi acquired partial rights to just four months ago.

119
119
article thumbnail

Medicare drug pricing negotiations: What comes next?

pharmaphorum

Explore the ins and outs of Medicare drug pricing negotiations with Alice Valder Curran on this insightful podcast. Learn more about what comes next in this crucial healthcare sector.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharma Pulse 9/12/24: AI Will Force a Transformation of Tech Infrastructure, Obesity Drug Market to be Worth $200 Billion by 2031 & more

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

105
105
article thumbnail

Darzi review must ‘spur ministers into action’ on community pharmacy

The Pharmacist

Community pharmacy leaders have called for urgent action to 'stop the rot' of pharmacy closures and to invest in the sector, following Lord Ara Darzi's report into the state of the NHS. The Darzi review - a major investigation into the NHS, commissioned by the government - praised the value of community pharmacies and preventative […] The post Darzi review must ‘spur ministers into action’ on community pharmacy appeared first on The Pharmacist.

article thumbnail

Mpox is on the rise again as outbreak gathers pace

pharmaphorum

Mpox is on the rise again as the latest outbreak gathers pace. Stay informed and learn more about the vaccine space for this infectious disease.

Vaccines 110
article thumbnail

EASD 2024: Innovent shows off mazdutide’s efficacy in diabetes and obesity

Pharmaceutical Technology

The data from two Phase III trials demonstrated GLP-1/glucagon agonist’s efficacy in reducing blood glucose and weight.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

LSX World Congress – Day Two

pharmaphorum

Join us for Day Two of LSX World Congress featuring presentations from top pharmaceutical companies like AstraZeneca, Takeda, Merck, Roche, Johnson & Johnson, Bayer and more. Get insights into the latest trends and innovations in the life sciences industry.

article thumbnail

Laughter may be as effective as drops for dry eyes

World Pharma News

Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ. The researchers suggest that laughter exercise could be an initial treatment for relieving symptoms of dry eye disease. Dry eye disease (DED) is a chronic condition estimated to affect around 360 million individuals worldwide.

87
article thumbnail

How measurement technology can advance sleep monitoring in clinical research and practice

pharmaphorum

Explore how digital measurement technology is revolutionising sleep monitoring in clinical research and practice. Learn about the latest advancements and benefits for improving sleep quality.

99
article thumbnail

HRT linked to reduced psychosis relapse risk in menopausal women

Pharma Times

New study highlights potential benefits of menopausal hormone therapy

114
114
article thumbnail

The ‘Rule of Three’: How the FDA is Hacking Drug Prices

Drug Patent Watch

In the labyrinthine world of pharmaceuticals, where the cost of life-saving medications can often feel like a roll of the dice, the FDA is implementing a strategy that aims to bring some much-needed transparency and affordability to the market. This strategy, known as the ‘Rule of Three,’ is a game-changer in the battle against soaring drug prices.